The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.
about
Optimal treatment and stochastic modeling of heterogeneous tumorsRadiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgeryThe tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?The biology of radiosurgery and its clinical applications for brain tumors.Radiobiology of radiosurgery for the central nervous systemRadiotherapy and the tumor stroma: the importance of dose and fractionationModeling cell survival and change in amount of DNA during protracted irradiation.High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-upPost-Surgery Glioma Growth Modeling from Magnetic Resonance Images for Patients with TreatmentConfirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamicsRe-irradiation: outcome, cumulative dose and toxicity in patients retreated with stereotactic radiotherapy in the abdominal or pelvic regionStereotactic body radiosurgery for spinal metastatic disease: an evidence-based reviewWhole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT techniqueLong-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment.Intraoperative radiotherapy in early stage breast cancer: potential indications and evidence to date.Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review.Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future?Local and Global Function Model of the LiverIntegral dose and radiation-induced secondary malignancies: comparison between stereotactic body radiation therapy and three-dimensional conformal radiotherapyHypofractionated external-beam radiotherapy for prostate cancer.Investigating the Implications of a Variable RBE on Proton Dose Fractionation Across a Clinical Pencil Beam Scanned Spread-Out Bragg PeakImpact of Fractionation and Dose in a Multivariate Model for Radiation-Induced Chest Wall Pain.Minimally invasive surgery using intraoperative electron-beam radiotherapy for the treatment of soft tissue sarcoma of the extremities with tendon involvementTo gate or not to gate - dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer.Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer.The biological effect of large single doses: a possible role for non-targeted effects in cell inactivation.Biology of high single doses of IORT: RBE, 5 R's, and other biological aspectsRadiosensitivity and relative biological effectiveness based on a generalized target model.Emerging applications of stereotactic body radiation therapy for head and neck cancer.The confluence of stereotactic ablative radiotherapy and tumor immunology.Accelerated partial breast irradiation in early breast cancer: focus on intraoperative treatment with electrons (ELIOT).Stereotactic body radiotherapy treatment of extracranial metastases.Hypofractioned radiotherapy in prostate cancer: is it the next step?Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications.Stereotactic body radiotherapy for head and neck cancer: an addition to the armamentarium against head and neck cancer.Markov chain Monte Carlo analysis for the selection of a cell-killing model under high-dose-rate irradiation.Therapeutic analysis of Intrabeam-based intraoperative radiation therapy in the treatment of unicentric breast cancer lesions utilizing a spherical target volume model.Radiobiology of stereotactic body radiation therapy (SBRT).A comprehensive model for heat-induced radio-sensitisation.A reaction-diffusion model for radiation-induced bystander effects.
P2860
Q26739901-9E9B67A7-5BA2-47A3-911E-D90BAA0AA08FQ26772259-61836FFB-9873-4BF3-B512-C1AE9328CB0BQ26823489-48F02A89-DFFB-4FD9-982A-A370C04DA144Q26829154-328ACEAD-532A-4616-9EFD-B574AABCADE9Q27011342-7EEDF010-0E1F-4625-B8A0-0A48E9125D25Q27022685-79CBDA7D-7F4A-4E13-AA2D-BF119C6C9B65Q30354249-12B508EF-796A-4C89-9AC2-CF1A2415592BQ33582598-C603782A-86F2-4C01-92D3-EC2001EB026CQ33683150-087FDBA2-6D22-4365-8288-4CDF2CB543E0Q34004539-8774E3D0-3BFD-4222-A01B-DC1A92F86458Q34262254-20EFE9DE-D7B6-45AF-A387-CC0DA48953F2Q35687568-1F801947-227D-48E9-9122-E83396EF1962Q35994140-EDF4C86C-076A-46F6-B5AB-671B0FAADDFAQ36143371-7C211C23-91A4-4D96-8DEB-64865ADA3753Q36235523-75290574-EF75-44AD-A7FE-605911BC3516Q36360066-8B4BFD88-528C-4CFE-93DF-6B108E38E478Q36365570-51DE934F-AEE2-4D33-AC75-49598A460B9EQ36407143-33F3CA44-70D7-42CA-80B8-ECEB3002F8B7Q36473560-537BD8A2-A2B3-49E7-A952-BC3713AD3642Q36711751-3B311B5A-5726-4441-9085-BE367B75432AQ36818883-5838345F-E670-4FE6-A44F-2615514A99FEQ36949855-9C1FAE18-9237-4350-9D7B-1E0FA9784C14Q37170377-74CFBE1D-B688-42A4-BB5E-9BE2C87745E2Q37278431-A5C7DE4B-6F24-4E7C-84E6-A8639C3C7D18Q37468265-4650FC2E-A223-460D-A0FE-EE845F129EFDQ37504688-E69CEAAD-78A1-4B26-B291-4045EA2C859EQ37597275-80275594-238A-42F7-9F91-E75775044F14Q37659259-44C79BB0-BDED-4ACB-978C-9DAFFB91B541Q37934972-F3E5E54B-9D1D-482C-89FA-15141E1D0422Q37967688-BA1A0B0F-B2CB-4121-9802-D27982D4AC60Q37968653-53C53DBA-862C-452D-AD26-FF9C82E37E0EQ38046079-F0E77683-2EA3-4A4D-8587-DAFB7B93BBD7Q38264783-043E095D-A9D4-457D-AF2C-E9373A899E18Q38435486-04BB13E3-8FC6-46EB-A739-72B57D7E9D1BQ38594442-A50D5842-500A-49A4-A21C-179D77F58211Q38635201-85BB002D-2677-47D1-A196-8AD76FBADF60Q38662704-BF83B956-E377-4A33-B3A6-0D252F566726Q38685466-0ED0CC4F-397E-4F6C-AFCF-C37619D41181Q38713464-BD1D5C3C-C9E2-4CF5-B7CE-DA5170B75458Q38723668-7319CAD7-AF9C-49EE-8E01-1BD32E70BF55
P2860
The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The linear-quadratic model is ...... s at large doses per fraction.
@en
type
label
The linear-quadratic model is ...... s at large doses per fraction.
@en
prefLabel
The linear-quadratic model is ...... s at large doses per fraction.
@en
P2860
P1476
The linear-quadratic model is ...... s at large doses per fraction.
@en
P2093
David J Brenner
P2860
P304
P356
10.1016/J.SEMRADONC.2008.04.004
P577
2008-10-01T00:00:00Z